Missed drug-induced bullous pemphigoid leads to longer immunosuppression than recognized cases: A 9-year retrospective review

J Am Acad Dermatol. 2020 May;82(5):1255-1258. doi: 10.1016/j.jaad.2019.12.059. Epub 2020 Jan 9.

Authors

Gabriel E Molina¹, Rebecca L Yanovsky², Erin X Wei³, Steven T Chen⁴

Affiliations

¹ Harvard Medical School, Boston, Massachusetts.
² Tufts University School of Medicine, Boston, Massachusetts.
³ Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts.
⁴ Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts; Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts. Electronic address: stchen@partners.org.

PMID: 31927075
DOI: 10.1016/j.jaad.2019.12.059

No abstract available

Publication types

Letter
Multicenter Study

MeSH terms

Aged
Aged, 80 and over
Anti-Bacterial Agents / adverse effects*
Biopsy
Delayed Diagnosis
Diuretics / adverse effects*
Drug Eruptions / diagnosis
Drug Eruptions / immunology*
Drug Eruptions / pathology
Female
Humans
Immune Tolerance / drug effects*
Male
Missed Diagnosis
Pemphigoid, Bullous / chemically induced*
Pemphigoid, Bullous / diagnosis
Pemphigoid, Bullous / immunology
Pemphigoid, Bullous / pathology
Polypharmacy
Retrospective Studies
Skin / immunology
Skin / pathology
Time Factors

Substances

Anti-Bacterial Agents
Diuretics